We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.
ikon GSK Antibiotic Dosage App

2.1 by Glaxo SmithKline PLC


May 20, 2018

Tentang GSK Antibiotic Dosage App

Sebuah aplikasi yang mudah digunakan untuk menghitung dosis antibiotik GSK

Developed by GSK, the GSK Antibiotic Dosage Calculator provides a quick, easy and hassle-free way for HCPs to compute for adult and paediatric antibiotic dosing for two of GSK’s antibiotic brands. With a sleek and intuitive user interface, the Dosage Calculator is able to compute between mild to severe antibiotic dose requirements, with just the swipe of a finger • For Medical/Healthcare Professionals in Malaysia only • Easily compute Adult & Paediatric dosage requirements for Augmentin® (amoxicillin-clavulanate) and Zinnat® (Cefuroxime) • “One-swipe” interface that computes dosage requirements with a single swipe of the patient weight slider • Computation algorithm based on Product Information data • Integrated Abbreviated Prescribing Information page for each brand • Full offline capability with no need for mobile data connections

Apa yang baru dalam versi terbaru 2.1

Last updated on May 20, 2018

• Updated Abbreviated Prescribing Information to current version.
• Minor bug fixes.

Terjemahan Memuat...

Informasi APL tambahan

Versi Terbaru

Permintaan GSK Antibiotic Dosage App Update 2.1

Diunggah oleh

Deborah Sousa

Perlu Android versi

Android 3.1+

Tampilkan Selengkapnya

GSK Antibiotic Dosage App Tangkapan layar

Bahasa
Berlangganan APKPure
Jadilah yang pertama mendapatkan akses ke rilis awal, berita, dan panduan dari game dan aplikasi Android terbaik.
Tidak, terima kasih
Mendaftar
Berlangganan dengan sukses!
Anda sekarang berlangganan APKPure.
Berlangganan APKPure
Jadilah yang pertama mendapatkan akses ke rilis awal, berita, dan panduan dari game dan aplikasi Android terbaik.
Tidak, terima kasih
Mendaftar
Kesuksesan!
Anda sekarang berlangganan buletin kami.